Compugen LTD income statement

In fiscal 2025, Compugen LTD reported revenue of $72.8m, up 161.1% on the year before, operating income of $31.3m (a 43.1% margin) and net income of $35.3m, or $0.38 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Compugen LTD: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2018Dec 2018	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	0	1	0	4	12	9	1	18	2	6	8	33	28	73
Cost of revenue	—	0	0	3	3	2	0	1	0	1	1	2	8	9
Gross profit	0	1	0	1	9	8	0	17	2	5	7	31	20	64
Research and development	5	5	9	12	15	21	25	30	23	29	31	34	25	23
Selling and marketing	—	—	—	—	—	—	0	0	0	—	—	—	—	—
General and administrative	2	3	3	5	5	6	7	8	10	11	10	10	9	9
Operating income	−8	−8	−14	−17	−12	−21	−33	−23	−31	−35	−35	−13	−15	31
Income before tax	—	−7	−14	−14	−11	−20	−31	−23	−30	−34	−34	−10	−10	35
Income tax	—	—	—	1	0	0	0	—	0	0	0	9	5	0
Net income	−4	−7	−14	−14	−11	−20	−32	−23	−30	−34	−34	−19	−14	35
Diluted EPS	−$0.13	−$0.22	−$0.38	−$0.36	−$0.26	−$0.40	−$0.62	−$0.41	−$0.37	−$0.41	−$0.39	−$0.21	−$0.16	$0.38
Diluted shares (average)	—	33m	36m	39m	48m	50m	51m	55m	80m	84m	87m	88m	90m	94m
EBITDA	−7	−8	−13	−17	−12	−20	−31	−22	−31	−35	−35	−13	−14	32

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CGEN vs VRDN CGEN vs WVE ASMB vs CGEN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Compugen LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Compugen LTD.